在西藏高海拔地区的肺栓塞综合内血管干预
1Respiratory Department, Changdu People's Hospital of Xizang, Changdu, China.
Frontiers in cardiovascular medicine
|October 28, 2024
概括
结合内血管干预有效地治疗高海拔藏族患者的肺栓塞 (PE). 这种疗法改善了生命体征,并无严重并发症缓解了症状,显示了它在具有挑战性的环境中的可行性.
科学领域:
- 心脏病学和干预性放射学.
- 高海拔医学 高海拔医学
- 肺血管疾病 肺血管疾病
背景情况:
- 由于环境和资源的限制,肺栓塞 (PE) 的管理在极高处是复杂的.
- 居住在高海拔地区的西藏患者对PE治疗提出了独特的挑战.
- 关于高海拔地区PE的干预治疗方法的数据有限.
研究的目的:
- 评估肺栓塞 (PE) 的结合内血管干预治疗的有效性和安全性.
- 评估这种治疗方法在极端高海拔地区的可行性.
- 分析在高海拔地区治疗的西藏PE患者的临床结果.
主要方法:
- 在西藏自治区诊断出PE的西藏患者的回顾性分析.
- 患者接受了结合的内血管干预疗法.
- 收集的数据包括患者人口统计,治疗细节和干预后生理参数.
主要成果:
- 9名西藏患者 (平均年龄62.0岁) 居住在3,863.4m接受治疗.
- 干预后,观察到心率 (p<0.05),呼吸率 (p<0.001) 和SpO2 (p<0.05) 的显著改善.
- 所有患者都经历了症状缓解 (呼吸不全,胸痛),没有严重的并发症,如出血.
结论:
- 结合内血管干预疗法是一种潜在的有益和可行的治疗急性PE在高海拔环境.
- 该研究表明,在具有挑战性的,资源有限的环境中,该研究表明了积极的临床结果和安全性.
- 这种方法为在高海拔地区的人口中管理PE提供了可行的选择.
更多相关视频
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
1.4K
02:58Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
Published on: December 22, 2023
341
相关概念视频
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
136
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
136
01:27Pneumothorax-II
121
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
121